News & Events

Clinical Program BL8040

Initiated Expansion Stage of Phase 2 Clinical Trial for Novel Treatment for Acute Myeloid Leukemia

BioLineRx Initiated Expansion Stage of […]

Regulatory Submission for Phase 2b Trial for Novel AML Consolidation Treatment

BioLineRx Announces Regulatory Submission for […]

BioLineRx Presents Multi-Year Clinical Development Plan for its BL-8040 Hematological Cancer Therapeutic Platform

BioLineRx Presents Multi-Year Clinical Development […]

BioLineRx Reports Positive Data from Ongoing Phase 2a Study for AML Treatment at ASH conference

BioLineRx Reports Positive Data from […]

Pre-Clinical Program

European Patent issued covering the composition and use of novel chemokine

Biokine Therapeutics Announces Issuance of […]